| Eurlex法規(guī)編號(hào)： |
(EU) 2024/2781 |
| OJ編號(hào)： |
OJ L, 2024/2781, 4.11.2024 |
| 中文標(biāo)題： |
2024年10月31日委員會(huì)實(shí)施條例(EU) 2024/2781：修訂實(shí)施條例(EU) No 540/2011，關(guān)于延長(zhǎng)活性物質(zhì)8-羥基喹啉、氨基吡唑啉、嘧菌酯、嗜油假絲酵母菌株O、氯蟲苯甲酰苯胺、氟啶、抑霉唑、甲基克雷松、甲溴脲、氟草醚、伏馬玫瑰擬青霉FE 9901菌株、特氟氯氰菊酯和特丁基鋅的批準(zhǔn)期 |
| 原文標(biāo)題： |
Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazine |
| 發(fā)布日期 |
2024-11-04 |
| 原文鏈接 |
查看歐盟官網(wǎng)文件 |
閱讀：665次
粵公網(wǎng)安備 44010602010620號(hào)